system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, RESULTS. Meshes: Animals, Blotting, Western, Cyclooxygenase 2, Galactosamine, Interleukin-6, Liver Cirrhosis, Experimental, Male, Monoterpenes, NF-kappa B, Nitric Oxide Synthase Type II, Protective Agents, RNA, Messenger, Rats, Rats, Wistar, Reverse Transcriptase Polymerase Chain Reaction, Silymarin, Tumor Necrosis Factor-alpha.
user
Does carvacrol suppress the expression of inflammatory marker genes in D-galactosamine-hepatotoxic rats? Context: To unravel the mechanism of anti-inflammatory activity of carvacrol in D-galactosamine (D-GalN)-induced hepatotoxic rats. The mRNA and protein expression levels of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and nuclear factor kappa-B (NF-κB) were assayed by semi-quantitative reverse transcriptase polymerase chain reaction (RTPCR) and western blot analysis. We found that the mRNA and protein expressions of TNF-α, IL-6, iNOS, COX-2 and NF-κB were significantly up-regulated in D-galactosamine induced hepatotoxic rats and treatment with carvacrol significantly down-regulated the expressions of these genes showing the mechanism behind the anti-inflammatory activity of carvacrol.
assistant
All above results reveal that the carvacrol well known anti-inflammatory activities in D-galactosamine induced hepatotoxic rats. Final Decision: yes